Cited by 541Cancer Genomics and DiagnosticsMyeloproliferative Neoplasms: Diagnosis and TreatmentAcute Myeloid Leukemia Research

Single-Cell Exome Sequencing and Monoclonal Evolution of a JAK2-Negative Myeloproliferative Neoplasm

Open access
Hou, Yong, Song, Luting, Zhu, Ping, Zhang, Bo, Tao, Ye, Xu, Xun, Li, Fuqiang, Wu, Kui +32 more·2012·Cell

Abstract

Tumor heterogeneity presents a challenge for inferring clonal evolution and driver gene identification. Here, we describe a method for analyzing the cancer genome at a single-cell nucleotide level. To perform our analyses, we first devised and validated a high-throughput whole-genome single-cell sequencing method using two lymphoblastoid cell line single cells. We then carried out whole-exome single-cell sequencing of 90 cells from a JAK2-negative myeloproliferative neoplasm patient. The sequencing data from 58 cells passed our quality control criteria, and these data indicated that this neoplasm represented a monoclonal evolution. We further identified essential thrombocythemia (ET)-related candidate mutations such as SESN2 and NTRK1, which may be involved in neoplasm progression. This pilot study allowed the initial characterization of the disease-related genetic architecture at the single-cell nucleotide level. Further, we established a single-cell sequencing method that opens the way for detailed analyses of a variety of tumor types, including those with high genetic complex between patients.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2012.02.028

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Rapid technological advances have enabled genome-wide profiling of RNA, DNA, protein, epigenetic modifications, chromatin accessibility, and other molecular events in single cells.

    “rapid technological advances have enabled genome-wide profiling of RNA7–10, DNA11–17, protein18–21, epigenetic modifications22–26, chromatin accessibility27,28, and other molecular events29 in single cells.”
  • Single-cell sequencing has been used to evaluate the clonal evolution of tumors.

    “Single-cell sequencing has already been used to evaluate the clonal evolution of tumors (Hou et al., 2012; Navin et al., 2011; Xu et al., 2012) and the spontaneous mutation of sperm cells (Lu et al., 2012; Wang et al., 2012).”

    From Genetic Changes Shaping the Human Brain (2015) · cites this paper as Hou et al., 2012

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hou, Y., Song, L., Zhu, P., Zhang, B., Tao, Y., Xu, X., Li, F., Wu, K., Liang, J., Shao, D., Wu, H., Ye, X., Ye, C., Wu, R., Jian, M., Chen, Y., Xie, W., Zhang, R., Chen, L., Liu, X., Yao, X., Zheng, H., Yu, C., Li, Q., Gong, Z., Mao, M., Yang, X., Yang, L., Li, J., Wang, W., Lu, Z., Gu, N., Laurie, G., Bolund, L., Kristiansen, K., Wang, J., Yang, H., Li, Y., Zhang, X., & Wang, J.
Affiliations
  • BGI Group (China) (CN)
  • Peking University First Hospital (CN)
  • Pfizer (United States) (US)
  • Kunming Institute of Zoology (CN)
  • State Key Laboratory of Digital Medical Engineering (CN)
Corresponding author
  • Li, Yingrui
  • Zhang, Xiuqing
  • Wang, Jun
Venue
Cell
Publisher
Elsevier BV
Published
2012-03
Volume
148
Issue
5
Pages
873-885
ISSN
0092-8674 (ISSN-L)
OpenAlex
W2034629821
Cited by
541
References
40
Citations by year
2026: 7 · 2025: 11 · 2024: 12 · 2023: 16 · 2022: 42 · 2021: 28 · 2020: 24 · 2019: 34 · 2018: 51 · 2017: 48 · 2016: 51 · 2015: 44 · 2014: 65 · 2013: 63 · 2012: 44
FWCI
22.78
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Health Sciences › Medicine › Genetics › Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
Keywords
single-cell whole-genome sequencing, tumor heterogeneity, clonal evolution, essential thrombocythemia, Sestrin2, NTRK1, driver gene identification, lymphoblastoid cell lines, cancer genomics
MeSH terms
Humans, Male, Middle Aged, Mutation, Myeloproliferative Disorders, Thrombocythemia, Essential, Genome, Human, Gene Expression Profiling, Janus Kinase 2, Single-Cell Analysis, High-Throughput Nucleotide Sequencing, Exome, Clonal Evolution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review